Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Torpy

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axisD J Torpy, J E Grice, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humansD J Torpy, J E Grice, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1995
Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophyJ E Grice, R V Jackson, G I Hockings, et al.
Alimentary Pharmacology & Therapeutics|March 7, 2018
Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitisH Philpott, M K Dougherty, C C Reed, et al.
Clinical and Experimental Pharmacology & Physiology|July 23, 1998
Pituitary-adrenal responses to combined oral D-fenfluramine and intravenous naloxone in humansJ E Grice, D J Torpy, G I Hockings, et al.
Metabolism: Clinical and Experimental|May 25, 1999
Lack of leptin suppression in response to hypersecretion of catecholamines in pheochromocytoma patientsA Böttner, G Eisenhofer, D J Torpy, et al.
Clinical Endocrinology|May 12, 2010
Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levelsJ T Ho, M J Chapman, S O'Connor, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patientsD J Torpy, C C Chen, N Mullen, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
New diagnostic tests for Cushing's syndrome: uses of naloxone, vasopressin and alprazolamR V Jackson, G I Hockings, D J Torpy, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotensionD J Torpy, A W Bachmann, J E Grice, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axisD J Torpy, J E Grice, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humansD J Torpy, J E Grice, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1995
Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophyJ E Grice, R V Jackson, G I Hockings, et al.
Alimentary Pharmacology & Therapeutics|March 7, 2018
Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitisH Philpott, M K Dougherty, C C Reed, et al.
Clinical and Experimental Pharmacology & Physiology|July 23, 1998
Pituitary-adrenal responses to combined oral D-fenfluramine and intravenous naloxone in humansJ E Grice, D J Torpy, G I Hockings, et al.
Metabolism: Clinical and Experimental|May 25, 1999
Lack of leptin suppression in response to hypersecretion of catecholamines in pheochromocytoma patientsA Böttner, G Eisenhofer, D J Torpy, et al.
Clinical Endocrinology|May 12, 2010
Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levelsJ T Ho, M J Chapman, S O'Connor, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patientsD J Torpy, C C Chen, N Mullen, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
New diagnostic tests for Cushing's syndrome: uses of naloxone, vasopressin and alprazolamR V Jackson, G I Hockings, D J Torpy, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotensionD J Torpy, A W Bachmann, J E Grice, et al.
Pageof 7